Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$149K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
3 of 6 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 2 business days late.
The 12 most recent Form 4 transactions.
| — |
| Filing ↗ |
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| Feb 9 | SNDX | Syndax Pharmaceuticals Inc | SSELL | 3,410 | $21.03 | $71.7K | -2.4% | Open the original filing on SEC.gov |
| Feb 6 | SNDX | Syndax Pharmaceuticals Inc | SSELL | 2,082 | $20.62 | $42.9K | -1.4% | Open the original filing on SEC.gov |
| Feb 4 | SNDX | Syndax Pharmaceuticals Inc | AGRANT◆ | 118,000 | $20.43 | $2.4M | — | Open the original filing on SEC.gov |
| Feb 4 | SNDX | Syndax Pharmaceuticals Inc | AGRANT | 30,750 | — | — | +26.7% | Open the original filing on SEC.gov |
| Feb 4 | SNDX | Syndax Pharmaceuticals Inc | AGRANT | 21,500 | — | — | +22.9% | Open the original filing on SEC.gov |
| Jan 30 | SNDX | Syndax Pharmaceuticals Inc | JOTHER | 1,219 | $8.48 | $10.3K | +1.3% | Open the original filing on SEC.gov |
| Dec 1, 2025 | SNDX | Syndax Pharmaceuticals Inc | GGIFT | 1,224 | — | — | -1.3% | Open the original filing on SEC.gov |
| Jul 31, 2025 | SNDX | Syndax Pharmaceuticals Inc | JOTHER | 1,226 | $8.43 | $10.3K | +1.3% | Open the original filing on SEC.gov |
| Jul 16, 2025 | SNDX | Syndax Pharmaceuticals Inc | SSELL | 1,296 | $9.29 | $12K | -1.4% | Open the original filing on SEC.gov |
| May 19, 2025 | SNDX | Syndax Pharmaceuticals Inc | PBUY | 3,000 | — | — | +3.3% | Open the original filing on SEC.gov |